Director/PDMR Shareholding

Regenersis plc

("Regenersis" or the "Company")

Director/PDMR Shareholding

Regenersis plc (the 'Company'), a strategic outsourcing partner to many of the world's leading consumer technology companies, received notification on 18 April 2012 of the following director dealing in the ordinary shares of 2 pence each in the Company ("Shares").

On 13 April 2012, Hanover Investment Partners - IX LLC acquired 192,743 Shares. The purchase price of these shares was 95 pence per Share.

On 16 April 2012, Hanover Investment Partners - IX LLC acquired 160,000 Shares. The purchase price of these shares was 91 pence per Share.

Matthew Peacock, Chairman of Regenersis, as a partner in Hanover Investors Management LLP, has an indirect beneficial interest in these shares. The combined resultant holding of Hanover Investors Management LLP and its connected parties is 8,388,351 ordinary shares equating to 18.72 per cent. of the issued share capital of the Company.

Enquiries:

Ends